Company profile: BrightSpec
1.1 - Company Overview
Company description
- Provider of analytical chemistry solutions using FT‑MRR and molecular rotational resonance spectroscopy for detailed molecular structure insights. Delivers quantum simulation software to predict and confirm rotational spectra, ultra‑high‑resolution measurements for precise identification and quantitation in complex mixtures, and rapid targeted analysis without front‑end separation for pharmaceutical and chemical applications.
Products and services
- Molecular Rotational Resonance Spectroscopy: Brightspec engineers laboratory-grade FT‑MRR spectroscopy that interrogates molecules’ unique rotational absorption and emission of electromagnetic radiation, yielding detailed molecular structure insights for analytical chemistry
- Selectivity: Brightspec delivers precision-calibrated measurement of rotational spectra with ultra-high resolution, enabling precise identification and quantitation of molecules in complex mixtures
- Simulation: Brightspec produces quantum-accurate software that predicts and confirms molecular rotational spectra through quantum simulation for accurate spectral characterization
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BrightSpec
Numerate
HQ: United States
Website
- Description: Provider of cloud-scale machine-learning-driven drug design and discovery, with a computational platform that predicts how potential drugs will behave in the lab and the body, combining data science, machine learning, cloud analytics, and medicinal chemistry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Numerate company profile →
Synthego
HQ: United States
Website
- Description: Provider of genome engineering platforms enabling access to CRISPR to accelerate life science R&D, leveraging machine learning, automation, and gene editing. Offers synthetic and synthesized sgRNA/gRNA for research and therapeutic development, GMP-grade and IND-enabling sgRNA for clinical trials and pre-IND studies, and the engineered hfCas12Max nuclease for higher on-target editing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synthego company profile →
Nanoplex Technologies
HQ: United States
Website
- Description: Provider of nanoparticle-based products for life science research, enabling ultra-sensitive molecular identification and quantitation, as well as authentication and tracking applications; focused on rapidly translating state-of-the-art nanoscience into practical, valuable products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanoplex Technologies company profile →
Cytena
HQ: Germany
Website
- Description: Provider of single-cell printing and isolation technologies for cell research and professional diagnostics, offering the cy-Clone device to separate single cells for biologics development and genetic analysis in cancer and stem cell research, and instruments including UP.SIGHT, C.SIGHT 2.0, B.SIGHT, CELLCYTE X, C.WASH PLUS, and the C.LIVE Caspase-3 Green NucView assay.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cytena company profile →
Stilla Technologies
HQ: France
Website
- Description: Provider of digital PCR solutions to accelerate next-generation genetic testing, including the Nio System, an all-in-one 7-color, continuous-loading instrument for high-throughput analysis; the naica System, a multiplex dPCR platform with up to six fluorescent channels; ready-to-use digital PCR kits and assays; chips and reagents; and analysis software for image analysis and data export.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stilla Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BrightSpec
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BrightSpec
2.2 - Growth funds investing in similar companies to BrightSpec
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BrightSpec
4.2 - Public trading comparable groups for BrightSpec
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →